文献速递细菌感染、耐药与抗菌药物医院感染防控

诊断方法、PCR核糖体型与艰难梭菌感染临床结局关联的变化:单中心经验

Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究在密歇根大学565例艰难梭菌感染(CDI)患者中,评估粪便毒素水平与PCR核糖体型同疾病严重度及不良结局的关系。结果显示毒素阳性与IDSA严重度相关但不预示不良结局;2016年核糖体106新出现(占10.6%),027型从16.5%降至9.3%,014-020型与IDSA严重度和30天死亡率相关(P=.001)。

要点

  • 毒素阳性(EIA和CCA)与IDSA严重度相关,但不预测30天死亡等不良结局。
  • 2016年核糖体106新出现占10.6%,027型由16.5%降至9.3%,014-020型稳定在18.9%。
  • 核糖体014-020型与IDSA严重度和30天死亡率相关(P=.001)。

核心结论

  • EIA和CCA毒素阳性与IDSA严重度相关,但与后续不良结局无关。
  • 艰难梭菌分子流行病学已发生变迁,可能影响CDI最佳诊断策略和临床严重度评估。

研究设计与样本

  • 密歇根大学单中心研究,共565例CDI患者,以EIA检测毒素A/B阳性或tcdB基因PCR阳性诊断。
  • 采用改良细胞毒性试验(CCA)定量粪便毒素水平,厌氧培养分离艰难梭菌并行PCR核糖体分型。
  • 严重CDI按IDSA标准定义,主要结局为30天全因死亡和30天内CDI归因的结肠切除、ICU入住和/或死亡的复合结局。
  • 分析包括双变量检验和逻辑回归。

主要发现

  • 199份样本经EIA诊断,447份经PCR诊断。
  • 毒素阳性与IDSA严重度相关,但与主要结局无关。
  • 2016年与2010-2013年相比,核糖体106新出现占10.6%,027型从16.5%降至9.3%,014-027型稳定在18.9%。
  • 核糖体014-020型与IDSA严重度和30天死亡率相关(P = .001)。

关键数值与推荐

  • 严重CDI定义采用IDSA标准。
  • 主要结局为30天全因死亡及30天内CDI归因的结肠切除、ICU入住和/或死亡复合结局。
  • 核糖体014-020型与30天死亡率相关P = .001。

临床怎么用

  • 毒素阳性可辅助判断IDSA严重度,但不应单独用于预测不良结局。
  • 核糖体分型变迁提示需关注当地分子流行病学以优化诊断策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In Clostridioides difficile infection (CDI), the relationship between clinical, microbial, and temporal/epidemiological trends, disease severity and adverse outcomes is incompletely understood. In a follow-up to our study from 2010-2013, we evaluate stool toxin levels and C. difficile polymerase chain reaction (PCR) ribotypes. We hypothesized that elevated stool toxins and infection with ribotype 027 associate with adverse outcomes. METHODS: In 565 subjects at the University of Michigan with CDI diagnosed by positive testing for toxins A/B by enzyme immunoassay (EIA) or PCR for the tcdB gene, we quantified stool toxin levels via a modified cell cytotoxicity assay (CCA), isolated C. difficile by anaerobic culture, and performed PCR ribotyping. Severe CDI was defined by Infectious Diseases Society of America (IDSA) criteria, and primary outcomes were all-cause 30-day mortality and a composite of colectomy, intensive care unit admission, and/or death attributable to CDI within 30 days. Analyses included bivariable tests and logistic regression. RESULTS: 199 samples were diagnosed by EIA; 447 were diagnosed by PCR. Toxin positivity associated with IDSA severity but not primary outcomes. In 2016, compared with 2010-2013, ribotype 106 newly emerged, accounting for 10.6% of strains, ribotype 027 fell from 16.5% to 9.3%, and ribotype 014-027 remained stable at 18.9%. Ribotype 014-020 associated with IDSA severity and 30-day mortality (P = .001). CONCLUSIONS: Toxin positivity by EIA and CCA associated with IDSA severity but not with subsequent adverse outcomes. The molecular epidemiology of C. difficile has shifted, which may have implications for the optimal diagnostic strategy for and clinical severity of CDI.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Menon A, Perry DA, Motyka J, et al. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience. Clin Infect Dis. 2021. PMID: 32930705. doi:10.1093/cid/ciaa1395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。